My Size Inc
For the period ended Sep 30, 2024. Filed Nov 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 14, 2024
MYSZ$0.69-5.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Interim Statements of Cash Flows
Condensed Consolidated Interim Statements of Cash Flows (Unaudited)
U.S. dollars in thousands
| Nine-Months Ended September 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flows from operating activities: | ||
| Net loss | (3,280) | (5,077) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation | 33 | 27 |
| Loss on disposition of property and equipment | 28 | - |
| Change in operating lease right-of-use asset | 142 | 130 |
| Amortization of intangible assets | 227 | 226 |
| Change in liabilities to related parties | (525) | 36 |
| Interest of long-term liabilities | 43 | 16 |
| Interest paid | (38) | (16) |
| Revaluation of investment in marketable securities | (1) | 21 |
| Change in Investment in JV | - | 52 |
| Stock based compensation | 306 | 290 |
| Change in inventory | 633 | (1,530) |
| Impairment of goodwill | 631 | - |
| Change in deferred tax liabilities | - | (328) |
| Change in account receivable | 285 | 1,165 |
| Changes in operating lease liabilities | (103) | (101) |
| Change in other receivables and prepaid expenses | (165) | (351) |
| Change in trade payables | (774) | 271 |
| Change in other payables | 35 | 259 |
| Net cash used in operating activities | (2,523) | (4,910) |
| Cash flows from investing activities: | ||
| Proceeds from investment in JV | 38 | - |
| Proceeds from short-term deposits | 22 | - |
| Net cash provided by investing activities | 60 | - |
| Cash flows from financing activities: | ||
| Proceeds from issuance of shares, net of issuance costs | 2,819 | 6,257 |
| Loans received | 500 | 350 |
| Repayment of loans | (693) | (377) |
| Net cash provided by financing activities | 2,626 | 6,230 |
| Effect of exchange rate fluctuations on cash and cash equivalents | (56) | 84 |
| Increase in cash, cash equivalents and restricted cash (*) | 107 | 1,404 |
| Cash, cash equivalents and restricted cash at the beginning of the period | 2,264 | 2,363 |
| Cash, cash equivalents and restricted cash at the end of the period | 2,371 | 3,767 |
| Non cash activities: | ||
| Change in operating lease right-of-use asset and liability | 181 | - |
| (*) | $184 relates to change in cash and cash equivalents and, $(77) to change in restricted cash for the nine months ended September 30, 2024. |
|---|
The accompanying notes are an integral part of the interim condensed consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.